Skip to main content
Client Work

The agents in Valeo Pharma’s US$3.1 million public offering.

Fasken
Reading Time 1 minute read
Share
  • LinkedIn

Overview

Client

Mackie Research Capital Corporation

Team

  • John M. Sabetti, Partner | Mergers & Acquisitions, Toronto, ON, +1 416 865 4455, jsabetti@fasken.com
  • Alex Nikolic, Partner | Mergers & Acquisitions, Toronto, ON, +1 416 865 4420, anikolic@fasken.com
  • Rachel Phillips, Partner | Corporate/Commercial, Toronto, ON, +1 416 865 5154, rphillips@fasken.com
  • Mark Vanderveken, Associate | Life Sciences, Toronto, ON, +1 416 943 8927, mvanderveken@fasken.com